Vimarsana
Biggest News Aggregation in the World

Page 2 - Device Exemption News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Device Exemption. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Device Exemption Today - Breaking & Trending Today

3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023 - Vimarsana News

3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023

3Spine, Inc., a medical device company developing a transformational alternative to lumbar spinal fusion, today announced achievement of US clinical trial enrol

3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023 - Vimarsana News

3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023

3Spine, Inc., a medical device company developing a transformational alternative to lumbar spinal fusion, today announced achievement of US clinical trial enrol

InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America - Vimarsana News

InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America

03.01.2024 - Appointment brings more than 30 years of medical technology general management and commercial leadership experience to the InspireMD team Reports inducement grant under NASDAQ listing rule 5635(c)(4) TEL AVIV, Israel and MIAMI, Jan. 03, 2024 ... Seite 1

OnPoint Vision Sees Clear Road Ahead - Orange County Business Journal - Vimarsana News

OnPoint Vision Sees Clear Road Ahead - Orange County Business Journal

OnPoint Vision has developed a 4.5 millimeter lens to help treat macular degeneration

Source: ocbj.com
MedAlliance and Cordis Join Forces in Landmark Medical Innovation Deal - Vimarsana News

MedAlliance and Cordis Join Forces in Landmark Medical Innovation Deal

Cordis has acquired MedAlliance, a Swiss-based medical technology company, in a transaction valued at USD 1.135 billion.